Residual mitral valve regurgitation after percutaneous mitral valve repair with the MitraClip® system is a risk factor for adverse one-year outcome.
about
Mortality after percutaneous edge-to-edge mitral valve repair: a contemporary reviewThe future of transcatheter mitral valve interventions: competitive or complementary role of repair vs. replacement?Quantitation of mitral regurgitation after percutaneous MitraClip repair: comparison of Doppler echocardiography and cardiac magnetic resonance imagingTwo-year outcomes after percutaneous mitral valve repair with the MitraClip system: durability of the procedure and predictors of outcome.Clinical outcomes of conventional surgery versus MitraClip® therapy for moderate to severe symptomatic mitral valve regurgitation in the elderly population: an institutional experienceA systematic review on the safety and efficacy of percutaneous edge-to-edge mitral valve repair with the MitraClip system for high surgical risk candidates.Percutaneous edge-to-edge mitral valve repair. Current clinical evidence with the MitraClip System.(Meta)-analysis of safety and efficacy following edge-to-edge mitral valve repair using the MitraClip system.The mitral-to-aortic flow-velocity integral ratio in the real world echocardiographic evaluation of functional mitral regurgitation before and after percutaneous repair.Percutaneous Mitral Valve Repair with MitraClip: Patient and Valve Selection for Optimal Outcome.MitraClip step by step; how to simplify the procedure.Previous malignancy is an independent predictor of follow-up mortality after percutaneous treatment of mitral valve regurgitation by means of MitraClip.Percutaneous mitral repair with the MitraClip system in patients with mild-to-moderate and severe heart failure: a single-centre experience.First experience of the usage of a GORE CARDIOFORM Septal Occluder device for treatment of a significant residual commissural mitral regurgitation jet following a MitraClip procedure.Optimal results immediately after MitraClip therapy or surgical edge-to-edge repair for functional mitral regurgitation: are they really stable at 4 years?
P2860
Q26750967-CD4394C8-1C3A-480B-8CDD-4A3ABA4053CBQ26860834-56520B24-68A4-4D9E-8737-662981FD146FQ30404510-3D5ACABF-DF8D-4C33-9170-6AEAFA80A743Q34333296-16E30554-AAF1-4C20-AC70-0141552C34F4Q36315216-07CE1A74-ED25-42E5-91E5-DB6B6F395CF3Q38118273-E28A9173-F6D3-4F49-97AD-1C59816F96C1Q38122117-E2294D88-45AE-41FE-A418-71B7A1FDA60BQ38358652-2EE09FA2-B46D-47C4-AFE2-0B99778D1DEAQ38694871-72DC8D91-E15D-446E-B439-93207FE17056Q38994799-9EAF0A08-3856-4E5C-9DB1-0F0DAF039843Q39033891-5EC250FE-7F84-4A0C-A04E-CAED1819DAD1Q40420165-06B25301-C046-4AEF-BABD-A72616570CE8Q45301848-28F912FB-19F3-4E50-8CC4-636C4B485E7DQ46643978-8D466F1B-92B7-46F3-9ACB-B4C821EEF786Q51420805-AED82553-1C84-4C24-83A1-7B00CCD5EF5D
P2860
Residual mitral valve regurgitation after percutaneous mitral valve repair with the MitraClip® system is a risk factor for adverse one-year outcome.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Residual mitral valve regurgit ...... for adverse one-year outcome.
@en
Residual mitral valve regurgit ...... for adverse one-year outcome.
@nl
type
label
Residual mitral valve regurgit ...... for adverse one-year outcome.
@en
Residual mitral valve regurgit ...... for adverse one-year outcome.
@nl
prefLabel
Residual mitral valve regurgit ...... for adverse one-year outcome.
@en
Residual mitral valve regurgit ...... for adverse one-year outcome.
@nl
P2093
P2860
P356
P1476
Residual mitral valve regurgit ...... for adverse one-year outcome.
@en
P2093
Christoph A Nienaber
Giuseppe D'Ancona
Gökmen R Turan
Hüseyin Ince
Ibrahim Akin
Ilkay Bozdag-Turan
Jasmin Ortak
Liliya Paranskaya
Stephan Kische
Tim Rehders
P2860
P304
P356
10.1002/CCD.24586
P577
2013-02-12T00:00:00Z